Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C6H13NO2 |
Molecular Weight | 131.1729 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H](C)[C@H](N)C(O)=O
InChI
InChIKey=AGPKZVBTJJNPAG-WHFBIAKZSA-N
InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1
Molecular Formula | C6H13NO2 |
Molecular Weight | 131.1729 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/25073372Curator's Comment: description was created based on several sources, including
https://www.drugbank.ca/drugs/DB00167 | https://www.ncbi.nlm.nih.gov/pubmed/22298573 | https://www.ncbi.nlm.nih.gov/pubmed/4698813 | https://www.ncbi.nlm.nih.gov/pubmed/28089725
Sources: https://www.ncbi.nlm.nih.gov/pubmed/25073372
Curator's Comment: description was created based on several sources, including
https://www.drugbank.ca/drugs/DB00167 | https://www.ncbi.nlm.nih.gov/pubmed/22298573 | https://www.ncbi.nlm.nih.gov/pubmed/4698813 | https://www.ncbi.nlm.nih.gov/pubmed/28089725
Isoleucine is an essential α-amino acid that is used in the biosynthesis of proteins. L-isoleucine is commonly used in parenteral and enteral nutrition. It is used in combination with the other branched chain amino acids to improve the nutritional status of patients with hepatic diseases. BCAAs serve as important fuel sources for skeletal muscle during periods of metabolic stress
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2221341 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22298573 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | FREAMINE III 10% Approved UseParenteral nutrition with 8.5% FreAmine® III (Amino Acid Injection) with Electrolytes is
indicated to prevent nitrogen loss or treat negative nitrogen balance in adults and pediatric
patients, where (1) the alimentary tract, by the oral, gastrostomy, or jejunostomy route, cannot or
should not be used, or adequate protein intake is not feasible by these routes; (2) gastrointestinal
absorption of protein is impaired; or (3) protein requirements are substantially increased as with
extensive burns. Dosage, route of administration, and concomitant infusion of non-protein
calories are dependent on various factors, such as nutritional metabolic status of the patient, anticipated duration of parenteral nutritional support, and vein tolerance Launch Date1971 |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
7.87 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/26119505/ |
50 mg/kg single, oral dose: 50 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
ISOLEUCINE plasma | Canis lupus population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
AUC
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
21.72 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/26119505/ |
50 mg/kg single, oral dose: 50 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
ISOLEUCINE plasma | Canis lupus population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1.45 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/26119505/ |
50 mg/kg single, oral dose: 50 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
ISOLEUCINE plasma | Canis lupus population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
PubMed
Title | Date | PubMed |
---|---|---|
A C-terminally elongated form of PHI from porcine intestine. | 1999 Nov 15 |
|
Lysine metabolism in higher plants. | 2001 |
|
An algorithm for mapping positively selected members of quasispecies-type viruses. | 2001 |
|
Structural investigation of cyclic peptidolipids from Bacillus subtilis by high-energy tandem mass spectrometry. | 2001 |
|
Leucine and protein metabolism in rats with chronic renal insufficiency. | 2001 Apr |
|
Regulation of a Rho-associated kinase expression during the corneal epithelial cell cycle. | 2001 Apr |
|
Distinguishing self from nonself: immunogenicity of the murine H47 locus is determined by a single amino acid substitution in an unusual peptide. | 2001 Apr 1 |
|
Coordinate changes in drug resistance and drug-induced conformational transitions in altered-function mutants of the multidrug transporter P-glycoprotein. | 2001 Apr 10 |
|
Dependence of the bi-functional nature of a sialyltransferase from Neisseria meningitidis on a single amino acid substitution. | 2001 Apr 20 |
|
Ester and hydroxamate analogues of methionyl and isoleucyl adenylates as inhibitors of methionyl-tRNA and isoleucyl-tRNA synthetases. | 2001 Apr 23 |
|
Recombinant tyrosine aminotransferase from Trypanosoma cruzi: structural characterization and site directed mutagenesis of a broad substrate specificity enzyme. | 2001 Apr 7 |
|
Metabolic regulation by leucine of translation initiation through the mTOR-signaling pathway by pancreatic beta-cells. | 2001 Feb |
|
Conformational preferences of heterochiral peptides. Crystal structures of heterochiral peptides Boc-(D) Val-(D) Ala-Leu-Ala-OMe and Boc-Val-Ala-Leu-(D) Ala-OMe--enhanced stability of beta-sheet through C-H...O hydrogen bonds. | 2001 Feb |
|
Recognition and stabilization of a unique CPRI--structural motif in cucurbitaceae family trypsin inhibitor peptides: molecular dynamics based homology modeling using the X-ray structure of MCTI-II. | 2001 Feb |
|
Comparison of in vitro systems of protein digestion using either mammal or fish proteolytic enzymes. | 2001 Feb |
|
Reduction of nonpolar amino acids to amino alcohols to enhance volatility for high-precision isotopic analysis. | 2001 Feb 15 |
|
Fragmentary form of thermostable leucine dehydrogenase of Bacillus stearothermophilus: its construction and reconstitution of active fragmentary enzyme. | 2001 Feb 2 |
|
Cloning and characterization of Chinese hamster homologue of yeast DBF4 (ChDBF4). | 2001 Feb 21 |
|
Extracellular amino acid profiles in the paraventricular nucleus of the rat hypothalamus are influenced by diet composition. | 2001 Feb 23 |
|
Blunted cardiac responses to receptor activation in subjects with Thr164Ile beta(2)-adrenoceptors. | 2001 Feb 27 |
|
Incidence of the endothelin receptor B mutation that causes lethal white foal syndrome in white-patterned horses. | 2001 Jan |
|
Precursor supply for polyketide biosynthesis: the role of crotonyl-CoA reductase. | 2001 Jan |
|
The Val-210-Ile pathogenic Creutzfeldt-Jakob disease mutation increases both the helical and aggregation propensities of a sequence corresponding to helix-3 of PrP(C). | 2001 Jan 12 |
|
Homoserine dehydrogenase from Saccharomyces cerevisiae: kinetic mechanism and stereochemistry of hydride transfer. | 2001 Jan 12 |
|
The basal turnover of yeast branched-chain amino acid permease Bap2p requires its C-terminal tail. | 2001 Jan 15 |
|
Protein control of the redox potential of the primary quinone acceptor in reactioncCenters from Rhodobacter sphaeroides. | 2001 Jan 30 |
|
Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis. | 2001 Jul 6 |
|
Identification of a novel single-nucleotide polymorphism (Val554Ile) and definition of eight common alleles for human IL4RA exon 11. | 2001 Mar |
|
Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein. | 2001 Mar |
|
Role of the Bacillus subtilis fatty acid desaturase in membrane adaptation during cold shock. | 2001 Mar |
|
Ligand migration in human myoglobin: steric effects of isoleucine 107(G8) on O(2) and CO binding. | 2001 Mar |
|
Mechanism of pH-dependent photolysis of aliphatic amino acids and enantiomeric enrichment of racemic leucine by circularly polarized light. | 2001 Mar 22 |
|
Thermodynamics of trimer-of-hairpins formation by the SIV gp41 envelope protein. | 2001 Mar 23 |
|
Structural and functional analysis of the HIV gp41 core containing an Ile573 to Thr substitution: implications for membrane fusion. | 2001 Mar 6 |
|
Direct comparison of experimental and calculated folding free energies for hydrophobic deletion mutants of chymotrypsin inhibitor 2: free energy perturbation calculations using transition and denatured states from molecular dynamics simulations of unfolding. | 2001 Mar 6 |
|
Why do female Aedes aegypti (Diptera: Culicidae) feed preferentially and frequently on human blood? | 2001 May |
|
Enzymology, structure, and dynamics of acetohydroxy acid isomeroreductase. | 2001 May |
|
The internal propeptide of the ricin precursor carries a sequence-specific determinant for vacuolar sorting. | 2001 May |
|
Dissociation pathways of alkali-cationized peptides: opportunities for C-terminal peptide sequencing. | 2001 May |
|
Does glutamine act as a substrate for transamination reactions in the liver of fed and fasted sheep? | 2001 May |
|
Reduction of large neutral amino acid levels in plasma and brain of hyperleucinemic rats. | 2001 May |
|
Role of surface lysine residues of adipocyte fatty acid-binding protein in fatty acid transfer to phospholipid vesicles. | 2001 May 29 |
|
Salmonella invasion gene regulation: a story of environmental awareness. | 2005 Feb |
|
Enantioselective and diastereoselective separation of synthetic pyrethroid insecticides on a novel chiral stationary phase by high-performance liquid chromatography. | 2007 Jul |
|
Rho-kinase-dependent F-actin rearrangement is involved in the inhibition of PI3-kinase/Akt during ischemia-reperfusion-induced endothelial cell apoptosis. | 2008 Mar |
|
Comparative genomic analysis uncovers 3 novel loci encoding type six secretion systems differentially distributed in Salmonella serotypes. | 2009 Aug 4 |
|
Imaging improves diagnosis of dementia with lewy bodies. | 2009 Dec |
|
[Surgical complications of renal transplantation from living donors: experience of the CHU Ibn Sina, Rabat]. | 2010 |
|
What is a microsatellite: a computational and experimental definition based upon repeat mutational behavior at A/T and GT/AC repeats. | 2010 |
|
The role of coupled positive feedback in the expression of the SPI1 type three secretion system in Salmonella. | 2010 Jul 29 |
Patents
Sample Use Guides
2.9g of L-isoleucine over 6 months
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28089725
Primary cultures of peripheral blood mononuclear cells were rinsed with PBS and harvested in phosphate buffer pH 7.4 (50 mmol/L KH2PO4, 1 mmol/L EGTA, 150 mmol/L sucrose). The reaction was started by the addition of a lucigenin mixture 5 μmol/L) and NADPH (100 μmol/L) (Sigma-Aldrich) to the protein sample in a final volume of 250 μL. Branched-chain amino acids were prepared as a mixture of leucine, isoleucine and valine at 0.2–12 mmol/L Cells were exposed to increasing concentrations of BCAA (4–12 mmol/L) for 1 h Chemiluminescence was determined every 2.4 s for 3 min in a microtiter plate luminometer (Enspire Perkin Elmer). Basal activity in the absence of NADPH was subtracted from each reading and normalized to protein concentration.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:02:26 GMT 2023
by
admin
on
Fri Dec 15 15:02:26 GMT 2023
|
Record UNII |
04Y7590D77
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LOINC |
25938-2
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
2510-6
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
53397-6
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
47673-9
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
20648-2
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
44329-1
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
53393-5
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
JECFA EVALUATION |
L-ISOLEUCINE
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
56689-3
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
57996-1
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
FDA ORPHAN DRUG |
93095
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
2509-8
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
DSLD |
173 (Number of products:424)
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
53152-5
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
47672-1
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
26965-4
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
55929-4
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
53154-1
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
32251-1
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
FDA ORPHAN DRUG |
33588
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
32252-9
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
17029-0
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
30052-5
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
47671-3
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
2507-2
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
32783-3
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
22714-0
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
53153-3
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
47676-2
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
47674-7
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
15138-1
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
13765-3
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
25939-0
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
DSLD |
2415 (Number of products:1910)
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
22659-7
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
26730-2
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
45214-4
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
2508-0
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
25450-8
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
NCI_THESAURUS |
C68442
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
CFR |
21 CFR 172.320
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
15131-6
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
9743-6
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
47675-4
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
72899-8
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
22706-6
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
13402-3
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
||
|
LOINC |
47677-0
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
04Y7590D77
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
17191
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
04Y7590D77
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
100000091969
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
C29598
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
1349502
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
6306
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
DB00167
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
ISOLEUCINE
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
6164
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
7798
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
SUB08320MIG
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
6033
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | RxNorm | ||
|
DTXSID1047441
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
24898
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
SUB21979
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
4129
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
30009
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
58045
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
m6495
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | Merck Index | ||
|
2095
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
73-32-5
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
46708
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
200-798-2
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
CHEMBL1233584
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY | |||
|
D007532
Created by
admin on Fri Dec 15 15:02:26 GMT 2023 , Edited by admin on Fri Dec 15 15:02:26 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
impurity A at 570 nm: maximum 0.8 per cent
CHROMATOGRAPHIC PURITY (TLC)
EP
|
||
|
PARENT -> IMPURITY |
impurity B at 570 nm
CHROMATOGRAPHIC PURITY (TLC)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |